Merkliste 
 1 Ergebnisse 
 
1

Anti-IgE (omalizumab) inhibits late-phase reactions and inf..:

Ong, Yee Ean ; Menzies-Gow, Andrew ; Barkans, Julia...
Journal of Allergy and Clinical Immunology.  116 (2005)  3 - p. 558-564 , 2005